India must manufacture more APIs locally, depend less on China: Experts India, the worlds third-largest drug producer by volumes, imports 70% of its APIs from China. For some APIs, especially antibiotics, dependence on China is over 90%. Indias top drug makers, including Dr Reddys, Lupin, Glenmark, Mylan, Zydus and Pfizer are dependent on China for APIs.
Pricing Covid-19 vaccines too high could backfire on big pharmaceutical companies A world without global intellectual property would be one of constant electronic warfare. State-backed hacking, such as China apparently tried with Moderna this week, would be a constant threat. Nor would companies enjoy a comfortable relationship with their own governments, who would see them less as engines of growth and more as storehouses of national wealth.
'Vaccine nationalism': Is it one country against other in the race for a Covid-19 shot? That's the fear of global health agencies planning a scheme to bulk-buy and equitably distribute vaccines around the world. They are watching with dismay as some wealthier countries have decided to go it alone, striking deals with drugmakers to secure millions of doses of promising candidates for their citizens.